Farms.com Home   News

Hope Remains For Decent Soybean Crop

Only about thirty per cent of Manitoba's soybeans have been harvested so far.
 
That number is far below the three-year average for this time of year which is 77 per cent.
 
Cassandra Tkachuk with Manitoba Pulse and Soybean Growers (MPSG) talked about the impact of the weekend storm.
 
"I would say most of them [soybeans] are still standing upright, but we have seen some lodging from that heavy, wet snow. The lodging might pose issues, but in the cases where we see it, it's not at significant parts of the field. So we're hopeful that by the time the snow melts and things dry up a little bit, to be able to get back on the fields that we can still take off some of those crops."
 
She says the majority of the damage to the soybeans was done before the snowfall, and was a result of the wetting and drying cycle that occurred.
 
If conditions allow, Tkachuk advises farmers to slow down while harvesting to avoid plugging the combine.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.